PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,074,000 | +82.0% | 1,293,289 | +68.2% | 0.01% | +50.0% |
| Q2 2020 | $2,238,000 | +4661.7% | 769,081 | +4533.0% | 0.00% | – |
| Q1 2020 | $47,000 | -92.5% | 16,600 | -91.4% | 0.00% | -100.0% |
| Q4 2019 | $630,000 | -26.9% | 194,000 | -51.4% | 0.00% | -50.0% |
| Q3 2019 | $862,000 | -85.0% | 398,950 | -78.1% | 0.00% | -84.6% |
| Q2 2019 | $5,732,000 | -40.1% | 1,825,381 | -29.1% | 0.01% | -43.5% |
| Q1 2019 | $9,576,000 | +2716.5% | 2,574,283 | +2098.3% | 0.02% | +2200.0% |
| Q4 2018 | $340,000 | +14.1% | 117,105 | -10.7% | 0.00% | 0.0% |
| Q1 2017 | $298,000 | – | 131,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |